Saturday, July 11, 2026

pharma · PCOS · Stomach Neoplasms

Renji Hospital

Renji Hospital clinical programs — 1 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Shanghai, CN HQ
608 Employees
NMPA registrant Type
Company details
Status
Public
HQ
Shanghai, CN
Employees
608
Programs
2
Drugs
3
Patents
0
Intelligence · Clinical Programs

Renji Hospital projects

1 ClinicalTrials.gov programs sponsored by Renji Hospital.

Renji Hospital has 1 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. Acarbose 100 MG

    RenJi Hospital

    PCOS

    approved small molecule active

    1 trial

Frequently asked questions

How many clinical projects does Renji Hospital have?

1 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.